Detalles de la búsqueda
1.
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
BMC Cancer
; 23(1): 663, 2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452287
2.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Eur J Cancer
; 200: 113587, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340384
Resultados
1 -
2
de 2
1
Próxima >
>>